Search - tctmd.com

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

Advertisement

PCI Reduces In-Hospital Mortality in Nonagenarians with STEMI

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Evidence Continues to Support Dabigatran Treatment in A-fib

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

A View to Future Trials: HORIZONS-AMI II and Others

STEMI Patient Population Evolves Over 15 Years

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Delayed PCI in Stable Patients with STEMI Still Beats Medical Therapy

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

DEB-AMI Published: Drug-Eluting Balloon Fails to Impress in STEMI

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content